Home Rituximab First treatment for children with rare vasculitis diseases approved First treatment for children with rare vasculitis diseases approved 30 Sep 2019 European Pharmaceutical Review Share on FacebookShare Share on XTweet Rituxan (rituximab) is the first approved treatment for children with rare vasculitis diseases, in which a patient's small blood vessels become inflamed.
C&C Group Bad news for anyone who drinks Bulmers or Tennent's as owners C&C make bombshell announcement 18 Apr 2024 1